Navigation Links
Wayne State embarks on study to improve identification of women at high risk of stroke
Date:1/25/2013

DETROIT A team of Wayne State University School of Medicine physicians will seek to develop methods to better identify women at increased risk for stroke using a new type of professional education grant.

The study, "Improving the Identification of Women at Increased Risk for Stroke in an Urban Medical Center," is funded by a $492,800 grant from Pfizer Inc. and will be overseen by Seemant Chaturvedi, M.D., WSU professor of neurology. Others involved in the study include Lavoisier Cardozo, M.D., F.A.C.P., F.R.C.P., professor of internal medicine and chief of the Division of Geriatric Medicine; Diane Levine, M.D., associate professor of internal medicine; Neelima Thati, M.D., professor of internal medicine; Maribeth Mateo, M.D., assistant professor of family medicine and public health sciences; and Ramesh Madhavan, M.D., D.M., assistant professor of neurology.

Chaturvedi and the team will study the rate of compliance for following recommended guidelines to identify women at risk for stroke by WSU and Wayne State University Physician Group (WSUPG) doctors in five WSUPG clinics. The findings will lead to a variety of live and online Continuing Medical Education activities designed to educate doctors on how to improve compliance with these guidelines. Later, the rate of patients receiving the appropriate screening and treatments to prevent stroke will be reassessed.

"The study will try to identify areas where stroke risk factor reduction is suboptimal," said Chaturvedi, who also serves as director of the Wayne State University/Detroit Medical Center Stroke Program. "For example, we will identify patients with hypertension not under control, patients with obesity not exercising, and patients with atrial fibrillation not being treated with anticoagulants. With education and medical alerts, we hope to improve treatment of these risk factors and more."

The study is part of a new emerging concept. Previously, pharmaceutical companies aw
'/>"/>

Contact: Julie O'Connor
julie.oconnor@wayne.edu
313-577-8845
Wayne State University - Office of the Vice President for Research
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Wayne State University researcher examines proteins role in diabetic retinopathy
2. Wayne State University researcher seeks to understand link between obesity, flu severity
3. Algae extract increases good cholesterol levels, Wayne State research finds
4. Wayne State develops better understanding of memory retrieval between children and adults
5. Wayne State research team finds possible clue to progression of MS
6. Wayne State researchers say adolescent smoking prevention programs still critical
7. Wayne State University researcher recognized by American Psychological Association
8. CDC funds Wayne State University research to understand, prevent teen dating violence
9. Wayne State researcher finds possible clue to childrens early antisocial behavior
10. Wayne State University researcher to evaluate success of text message diabetes intervention
11. Study reveals how cancer drug causes diabetic-like state
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... 2015 As the Muscular Dystrophy Association ... the organization has hired two new Scientific Program Officers, ... will report to Grace Pavlath, Ph.D, who joined MDA ... Program Director, and together will lead MDA as it ... cures for various types of neuromuscular and motor neuron ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 US Sports ... three Maryland camps – two non-contact specialty camps and ... run by Perfect Performance Training, located at Bowie State ... on developing position specific skills, speed and strength of ... at Salisbury University with Marvin Graves, former quarterback in ...
(Date:3/6/2015)... 2015 Johnson & Johnson and Ethicon ... March 5, 2015 in Superior Court in the State ... a jury of 12 awarded Mrs. Perry $700,000 in ... with an Ethicon TVT Abbrevo plastic sling for stress ... women also awarded $5 million in punitive damages. , ...
(Date:3/6/2015)... Jvion, the Atlanta-based leader in ... Clostridium Difficile (C Diff) predictive use case for ... case is the latest in a broad compliment ... chronic conditions, and individual illnesses. Using the firm’s ... flags at risk individuals to help support clinician ...
(Date:3/6/2015)... In a new study conducted at a ... that shoulder pain was their first mesothelioma symptom. Surviving Mesothelioma ... Click here to read it now. , Doctors at ... of 49 mesothelioma patients between 2006 and 2012 ... shoulder pain that first prompted them to see a doctor. ...
Breaking Medicine News(10 mins):Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 2Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 4Health News:US Sports Camps to Host Three New Football Camps in Maryland 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 3Health News:Jvion Predicts Patients at Risk of C Difficile Infection to Reduce Risk and Save Lives 2Health News:New Report Reveals Shoulder Pain Could Signal Early Mesothelioma, According to Surviving Mesothelioma 2
... Researchers from Harvard School of Public Health (HSPH), Massachusetts ... Research (NBER), and Providence Health & Services have found ... increases health care use, reduces financial strain on covered ... is the first study to evaluate the impact of ...
... today [Thursday 7 July] at the Annual Scientific Meeting of ... the Academic Unit of Primary Health Care, University of Bristol. ... 2008, uses HPV vaccine that is effective against the two ... offers 70 per cent protection against cervical cancer. However, ...
... 6, 2011) One consequence of the expanded access to ... shortfall in the necessary numbers of physicians and other advanced ... issue of the Journal of the American College of ... the combined workforce of physicians, advance practice nurses, and physician ...
... HealthDay Reporter , WEDNESDAY, July 6 (HealthDay ... multiple sclerosis have been dimmed by recent research in ... found no support for prior studies connecting breast-feeding with ... disorder commonly known as MS. Instead, they ...
... , WEDNESDAY, July 6 (HealthDay News) -- Airline pilots ... debilitating fatigue that could hamper their flying performance, a ... U.S. Federal Aviation Administration should find ways to reduce ... to the report from the U.S. National Research Council. ...
... HealthDay Reporter , WEDNESDAY, July 6 (HealthDay News) -- ... rise in various parts of the country, and this one ... by a microscopic parasite that attacks blood cells, causing flu-like ... Lyme disease, which is caused by bacteria, babesia microti parasites ...
Cached Medicine News:Health News:Medicaid increases use of health care, decreases financial strain, improves health 2Health News:Medicaid increases use of health care, decreases financial strain, improves health 3Health News:Lack of clarity about HPV vaccine and the need for cervical cancer screening 2Health News:Future labor shortfalls of medical professionals predicted due to new demands of health-care reform 2Health News: Breast-Feeding May Not Protect Moms Against MS Relapse 2Health News: Breast-Feeding May Not Protect Moms Against MS Relapse 3Health News:Long Commutes for Pilots May Hamper Flying Performance: Study 2Health News:Long Commutes for Pilots May Hamper Flying Performance: Study 3Health News:Long Commutes for Pilots May Hamper Flying Performance: Study 4Health News:A Deadly New Reason to Avoid Deer Ticks 2Health News:A Deadly New Reason to Avoid Deer Ticks 3
(Date:3/5/2015)... Germany , March 5, 2015 ... today announced that the foundation has made a ... CureVac, a leading clinical-stage biopharmaceutical company specializing in ... the foundation will also provide separate funding for ... CureVac,s proprietary messenger RNA (mRNA) platform. In addition, ...
(Date:3/5/2015)... , March 5, 2015  Sanomedics, Inc. (OTC: SIMH, ... company focused on developing, manufacturing, and acquiring cutting-edge technology, ... Thermomedics, Inc., will be exhibiting at booth # 709 ... Conference (NAPNAP) taking place on March 11-13, 2015 ... The 36 th ...
(Date:3/5/2015)... N.Y. , March 5, 2015  AMRI (NASDAQ: ... Pettersson , fills the newly created position of VP ... Christopher Conway , Senior Vice President of Global Sales ... Pettersson will lead the international sales team in an ... share in targeted market segments. Mr. Pettersson will drive ...
Breaking Medicine Technology:The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology 2The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology 3The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology 4Sanomedics to Showcase the Caregiver at National Association of Pediatric Nurse Practitioners Conference 2Sanomedics to Showcase the Caregiver at National Association of Pediatric Nurse Practitioners Conference 3AMRI Hires VP of International Sales 2
... , June 30 /PRNewswire-Asia-FirstCall/ -- Concord Medical Services,Holdings Limited ("Concord ... network of radiotherapy and diagnostic imaging centers in China ,today announced ... , , ... the program, Concord Medical is authorized to repurchase up to US$20,million ...
... DIEGO , June 30 ADVENTRX Pharmaceuticals, Inc. (NYSE ... performed on samples of ANX-530 (vinorelbine injectable emulsion), or Exelbine™, manufactured ... are on track to support the submission of a New Drug ... , , ...
Cached Medicine Technology:Concord Medical Announces Share Repurchase Program 2Concord Medical Announces Share Repurchase Program 3ADVENTRX Announces 9-Month Stability Data Results for ANX-530 2ADVENTRX Announces 9-Month Stability Data Results for ANX-530 3
Lyphochek Hemostasis Control is a multi-analyte control to help monitor coagulation factor assays and selected thrombosis risk assays. Assayed values are available for most major instrumentation....
... Liquichek Qualitative Urine Toxicology Control is a ... rapid urine drug screen panels, including Point ... test kits like Bio-Rad TOX/See, Biosite Triage ... qualitative results (+/) for popular kits and ...
Liquichek Reticulocyte Control is a human whole blood based control designed to monitor manual and automated methods for counting reticulocytes. Assayed values are provided at three clinically signif...
Liquichek Hematology Control (C) is an assayed hematology control for evaluating the performance of Coulter hematology instruments with complete CBC and VCS 5-part differential technology....
Medicine Products: